← Back to Home
Swing·Markets Desk·Tue, 7 Jul
Multi-Day Momentum: NATCOPHARM Leads a 5-Stock Swing Watchlist
Icms1 and 3 other desks issued 5 swing trade recommendations targeting 2–5 day holding periods on broadly bullish chart setups.
By Markets Desk·7 Calls·7 Buy
Icms1 and 3 other registered desks issued 7 equity swing recommendations today, targeting price setups over a 2 to 5 day holding window. The batch carries a bullish bias — 7 buys against 0 sells — covering 5 stocks.
NATCOPHARM attracted 2 separate recommendations from registered analysts — Icms1 issued a buy at ₹965 targeting ₹1,010 (stop ₹940); PLTechnicalResearch issued a buy at ₹952 targeting ₹1,000 (stop ₹930).
HDFCLIFE was flagged for a buy by PLTechnicalResearch at ₹568, targeting ₹585 — a potential upside of +3.0%, with a stoploss at ₹558. The risk-to-reward ratio stands at 1:1.7.
APLAPOLLO attracted 2 separate recommendations from registered analysts — KotakSecurities issued a buy at ₹1,825 targeting ₹1,940 (stop ₹1,770); KotakSecurities issued a buy at ₹1,825 targeting ₹1,900 (stop ₹1,770).
Also covered: KPITTECH (₹565 → ₹585) via PLTechnicalResearch; SBILIFE (₹1,835 → ₹1,903) via Nirmalbangofficial.
Swing positions are typically held for two to five sessions. Track broader index levels and avoid holding through major macro events without adjusting stoplosses.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
Icms1PLTechnicalResearchKotakSecuritiesNirmalbangofficial
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.